A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas-Reference-Cited by-同舟云学术

A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas

Published:2016-08-31 Issue:11 Volume:65 Page:1353-1364
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Duggan Megan C.,Jochems Caroline,Donahue Renee N.,Richards Jacob,Karpa Volodymyr,Foust Elizabeth,Paul Bonnie,Brooks Taylor,Tridandapani Susheela,Olencki Thomas,Pan Xueliang,Lesinski Gregory B.,Schlom Jeffrey,Carson III William E.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1893-7.pdf

Reference48 articles.

1. American Cancer Society (2016) Key statistics for colorectal cancer. Am Cancer Soc. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics . Accessed 24 Mar 2016

2. Demols A, Van Laethem J-L (2002) Adjuvant chemotherapy for colorectal cancer. Curr Gastroenterol Rep 4:420–426

3. Gustavsson B, Carlsson G, Machover D et al (2015) A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 14:1–10. doi: 10.1016/j.clcc.2014.11.002

4. Folprecht G, Hamann S, Schütte K et al (2014) Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer. BMC Cancer 14:521. doi: 10.1186/1471-2407-14-521

5. Marques AM, Turner A, de Mello RA (2014) Personalizing medicine for metastatic colorectal cancer: current developments. World J Gastroenterol 20:10425–10431. doi: 10.3748/wjg.v20.i30.10425

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

2. Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer;International Journal of Molecular Sciences;2024-03-19

3. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

4. CEA vaccines;Human Vaccines & Immunotherapeutics;2023-12-13

5. Recombinant strains of oncolytic vaccinia virus for cancer immunotherapy;Биохимия;2023-06-15